Simone Song's ORI Capital closes $260M second fund after CG Oncology success
22 Feb 2024
Executive ChangeIPO
Simone Song recalls discussing oncolytic virus therapies with her father and son “under the moonlight, like a family scientific symposium” in Southern California in 2014. After the intergenerational discussion, she posted to WeChat about the subject and, through business connections, was eventually led to Arthur Kuan.
Song, then a managing director for Greater China healthcare investment banking at Goldman Sachs, would go on to launch her own healthcare VC firm, ORI Capital, a year later. And in 2017, ORI invested in the bladder cancer therapy at CG Oncology, which Kuan stepped into as CEO after previous management ran into troubles with a clinical hold, loss of a CDMO contract and cash reserves that withered to the point of just six weeks of runway, she said.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.